A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. - Wikidata - wikimedia - TriplyDB

A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.

A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.

http://www.wikidata.org/entity/Q46345968

about

EUROCarbDB: An open-access platform for glycoinformatics Mass Spectrometry-Based N-Glycomics of Colorectal Cancer The Role of Glycosylation in Breast Cancer Metastasis and Cancer Control Serum glycoprotein-derived N- and O-linked glycans as cancer biomarkers Simultaneous analyses of N-linked and O-linked glycans of ovarian cancer cells using solid-phase chemoenzymatic method Solvent interaction analysis as a proteomic approach to structure-based biomarker discovery and clinical diagnostics.Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins.Protein modifications as potential biomarkers in breast cancer.Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.High-mannose glycans are elevated during breast cancer progression Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer.Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008.Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery.Tumour-associated carbohydrate antigens in breast cancer.Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.The development of an integrated platform to identify breast cancer glycoproteome changes in human serum.Characterization of glycoproteins in pancreatic cyst fluid using a high-performance multiple lectin affinity chromatography platform.The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases.The potential role of ORM2 in the development of colorectal cancer.N-glycan profiling by microchip electrophoresis to differentiate disease states related to esophageal adenocarcinoma.N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation.Structural glycomic analyses at high sensitivity: a decade of progress A quantitative investigation of fucosylated serum glycoproteins with application to esophageal adenocarcinoma Glycomic analysis by glycoprotein immobilization for glycan extraction and liquid chromatography on microfluidic chip.Serum glycan signatures of gastric cancer.Overexpression of α2,3sialyl T-antigen in breast cancer determined by miniaturized glycosyltransferase assays and confirmed using tissue microarray immunohistochemical analysis.N-glycomic profiling as a tool to separate rectal adenomas from carcinomas.The emerging importance of α-L-fucose in human breast cancer: a review.Aberrant glycosylation associated with enzymes as cancer biomarkers.Protein biomarkers for the early detection of breast cancer.Development of recombinant Aleuria aurantia lectins with altered binding specificities to fucosylated glycans.Glycopeptide Site Heterogeneity and Structural Diversity Determined by Combined Lectin Affinity Chromatography/IMS/CID/MS Techniques.Revealing Glycoproteins in the Secretome of MCF-7 Human Breast Cancer Cells.N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.Structural Characterization of Serum N-Glycans by Methylamidation, Fluorescent Labeling, and Analysis by Microchip Electrophoresis.Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer.Integrated mass spectrometry-based analysis of plasma glycoproteins and their glycan modifications.Chemoenzymatic method for glycomics: Isolation, identification, and quantitation.Exploring Glycan Markers for Immunotyping and Precision-targeting of Breast Circulating Tumor Cells.Analytical glycobiology at high sensitivity: current approaches and directions

P2860

Q24602364-9BE5E153-39CD-456B-B1FF-5928BEEAA4CC Q26774414-4413BF6D-D41A-4188-9C0B-8AD2F293B9A2 Q26777141-89B4FFF7-6FD6-4770-8066-AF05A5CA0466 Q28079101-7C0D144D-8825-42AC-94E5-4A31035E9623 Q28468580-457321AE-9CDE-4DEA-9008-7CCBE7252DD5 Q30381260-A8CF5A97-35DA-4960-ABB9-50AB31A0FC09 Q33546544-1B94C6B0-0C1F-44E5-BB39-F63228B548A7 Q33586407-CC899F2F-1FCE-441D-BC0D-A5EF97B7462E Q33682219-A63F2FBA-AAC9-456C-B136-BF24C20126A6 Q33753523-92366D7A-4274-4966-BC63-E8B0E9A10D77 Q33888457-E1F3058B-45DD-43C5-B88F-042CE5F45B06 Q33995843-A9C858BE-F396-4440-A545-91D48886182D Q34022368-0875D3FE-E21E-4B8F-B73F-C2C0F20F9DAF Q34048052-20F97D92-DD43-40E2-A823-39F871BF9989 Q34058682-533BEE46-2020-4B77-B3FA-451FB7948584 Q34080000-823B042D-ADCA-4A2B-981A-716F301B390C Q34080008-6CE1E253-7006-4B4D-82FA-BE5C71A25241 Q34092935-2A7C8C56-225F-445B-9CAE-97478331A95B Q34171477-CC829129-8C4B-498F-847F-1E34E3B3AA71 Q34187614-83614722-BEEA-46ED-B43A-960F1EE470BF Q34264310-F6AD8BAB-92F2-440A-80CB-DC42B9C370AC Q34656853-609748A7-5EB7-401F-9CF2-A01ACF760E06 Q34808751-0E9A7A2B-85CA-4BC9-87E7-F0142B2C8BDB Q35013214-97F14ACB-EFD9-4123-AF29-998E9B4F9754 Q35064779-EFF29526-FC83-4F67-8A2F-6DD5E53A46B2 Q35069229-AB8B319A-C319-4854-A507-F8A13D658544 Q35148539-E9768B7C-FAF2-4644-ABC7-AC519C741530 Q35172546-06749F80-B4B7-4492-8A3C-2BD6C691027E Q35206309-4A1FD9E3-FF61-4B06-A16A-9417762FEB0F Q35367572-4371CB74-E2D1-4591-A75A-3BABB4EB70FB Q35450855-F60ED1DF-090F-4BD2-AFCB-50CD1953A37B Q35763008-6396F7D1-3437-45E9-8D8F-BE15B1957078 Q35807042-A2F3EE6E-1C34-425A-AA4D-25E8EE82C6B9 Q35874750-61BE8BE3-7C61-480E-AA85-0DBD78B607A5 Q36098576-43BE5CBA-056A-498B-9872-EFB2B292557C Q36339643-79A40E41-AAD0-4559-AA64-5FD3927AE971 Q36368396-CA50AAA3-6BD2-4012-B94C-DF44E46638C9 Q36471241-0854F21C-DFF0-49B9-8C6A-9F04E4EB8B77 Q36510283-D73FB834-4DAB-40B7-B8F1-D2D559E5E3FA Q36651493-20735157-EF82-42A1-8816-017DA4B49572

P2860

A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.

http://www.wikidata.org/entity/Q46345968

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

A strategy to reveal potential ...... ith breast cancer progression.

@en

A strategy to reveal potential ...... ith breast cancer progression.

@nl

type

label

A strategy to reveal potential ...... ith breast cancer progression.

@en

A strategy to reveal potential ...... ith breast cancer progression.

@nl

prefLabel

A strategy to reveal potential ...... ith breast cancer progression.

@en

A strategy to reveal potential ...... ith breast cancer progression.

@nl

P1433

Q46345968-C328E8C7-C368-4BC6-A9BA-CF1111996788

P1476

Q46345968-9759E689-B6B5-43CA-B91F-A14BF366D411

P2093

Q46345968-044C797C-584A-4AD1-9EAD-A98E92C80809

Q46345968-05D7EDD6-5CBD-47CC-A1D1-A25CB703EBA8

Q46345968-06571D81-83BE-4430-AB4D-09A351FFC2D7

Q46345968-1534C37E-2D64-466F-967E-28BBFDD7E1AA

Q46345968-2B61D1F5-6FD7-47A7-A5F2-B07DEE7366FE

Q46345968-4AB1B266-3DD2-43FA-8CBC-095939AED0AC

Q46345968-61839EAF-D104-472E-AC1A-98653AE1B6B5

Q46345968-96B53E83-7DC9-42A9-AAE7-668F38908003

Q46345968-C04424E4-97FB-47FB-800E-DED238CFD6E2

Q46345968-DB2E0F40-AE67-4C60-98E0-0352C1020C3F

P304

Q46345968-E0F3667F-010F-410B-893F-489124C34D0F

P31

Q46345968-6C49D3FA-C174-410E-8F70-0062B7536FB7

P356

Q46345968-8631977B-AD66-483E-8FD1-12D307452D58

P433

Q46345968-418264EF-B08D-4A9A-9B6D-2DE1E486711D

P478

Q46345968-2A3815B0-4DE2-47FF-A85F-A7DF5DD33488

P50

Q46345968-3E1F5D53-9FCD-4B8E-8CEE-ED6FCE4B961F

Q46345968-96CD0604-3FEF-443C-88EC-C00F0E310D9A

Q46345968-D1ACD2AA-3CFF-4144-AB70-72679851B33E

P577

Q46345968-EF873B2F-FAC1-4DF4-A553-8385CD39A162

P5875

Q46345968-9E0409E2-0953-431F-AD00-AB3BBB8AF4E9

P698

Q46345968-2F4ABDA3-32E9-4EB4-9133-2BD7A564C1A9

P356

P1433

P1476

A strategy to reveal potential ...... ith breast cancer progression.

@en

P2093

Caroline J Chapman

http://www.w3.org/2001/XMLSchema#string

Catherine M Radcliffe

http://www.w3.org/2001/XMLSchema#string

David J Harvey

http://www.w3.org/2001/XMLSchema#string

John F Robertson

http://www.w3.org/2001/XMLSchema#string

Louise Royle

http://www.w3.org/2001/XMLSchema#string

Nicole Zitzmann

http://www.w3.org/2001/XMLSchema#string

Pauline M Rudd

http://www.w3.org/2001/XMLSchema#string

Radka Saldova

http://www.w3.org/2001/XMLSchema#string

Raymond A Dwek

http://www.w3.org/2001/XMLSchema#string

Robin Antrobus

http://www.w3.org/2001/XMLSchema#string

P304

1105-1118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/GLYCOB/CWN095

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Umi M Abd Hamid

P577

2008-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23282308

http://www.w3.org/2001/XMLSchema#string

P698

18818422

http://www.w3.org/2001/XMLSchema#string